NCX 470 Shows Dual Mechanism for IOP Lowering in Glaucoma Studies
Recent studies presented at the American Glaucoma Society meeting have highlighted the potential benefits of NCX 470, a nitric oxide-donating bimatoprost eye drop designed to reduce intraocular pressure (IOP) in … Read More